Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VISmodegib for ORbital and Periocular Basal Cell Carcinoma (VISORB)

NCT02436408 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT02436408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02436408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VISmodegib for ORbital and Periocular Basal Cell Carcinoma (VISORB)
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Phase 4
Overall status
Completed
Start date
July 15, 2015
Completion date
September 30, 2020
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, basal cell